Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInsig Ai Plc Regulatory News (INSG)

Share Price Information for Insig Ai Plc (INSG)

Share Price is delayed by 15 minutes
Get Live Data
14.00    0.00 (0.00%)
Bid:
13.50
Ask:
14.50
Spread: 1.00 (7.407%)
Market Cap: £17.67m
INSG Live PriceLast checked at - London Stock Exchange

Intraday Insig Ai Plc Share Chart

AGM Statement

15 Sep 2023 07:00

RNS Number : 5266M
Insig AI Plc
15 September 2023
Β 

15 September 2023

Insig AI plc

("Insig AI" or the "Company")

AGM Statement

At today's Annual General Meeting of Insig AI plc (AIM:INSG), the data science and machine learning solutions company, Executive Chairman, Richard Bernstein will comment: "A month ago, we provided an update, where I said that in the coming months, through partnerships, distribution agreements and direct selling, we expect to monetise our offering and that we were excited about both our market positioning and our prospects. That remains the case. In recent weeks, we have continued to progress our discussions with several parties to that end.

I am now pleased to report that the Financial Conduct Authority ("FCA"), has invited Steve Cracknell, our Chief Product Officer, to be a judge at the Showcase Day for the GFIN #Greenwashing TechSprint on 20 September 2023. We believe that this is a demonstration of our deep involvement in this important initiative, which has brought together international regulators, the World Bank and important corporates.

Over the last few months, we have had significant and meaningful interaction, with both corporates and international regulators. We have been incredibly impressed by the understanding, rigour and determination of the FCA to be at the forefront of using technology to enable adherence to the highest standards of corporate disclosures and transparency. We are also delighted that nearly all of the participants within the programme used our dataset of machine-readable corporate disclosures and text interrogation tools in order to develop their solutions. I believe that our commitment to this programme and the substantial investment that we have made, is about to serve us well."

Β 

The AGM, commencing at midday, can be accessed by:

https://us06web.zoom.us/j/84006516350?pwd=U3BVTFJ4V1RNbU1PWEVWQW9oQ2JkQT09

Meeting ID: 840 0651 6350

Passcode: 437237.

Β 

For further information, please visitΒ www.insg.aiΒ or contact:

Insig AI plc

Colm McVeigh, CEOΒ 

Β 

Zeus (Nominated Adviser & Broker)

David Foreman / James Hornigold / Danny Phillips

Β 

Β 

+44 (0) 203 829 5000

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMBZLLFXKLEBBE
Date   Source Headline
6th Sep 20247:00 amRNSDirector/PDMR Dealing
1st Aug 20247:00 amRNSDirector/PDMR Dealing
3rd Jul 20247:00 amRNSConvertible Loan Notes
21st Jun 20242:30 pmRNSHolding(s) in Company
10th Jun 202411:36 amRNSHolding(s) in Company
6th Jun 20247:00 amRNSGrant of options
5th Jun 20247:00 amRNSEquity Subscription and TVR
30th May 20246:28 pmRNSDirector/PDMR Dealing
30th May 20247:02 amRNSShare subscription, director dealing and TVR
30th May 20247:01 amRNSStrategic investment, revenue share and TVR
30th May 20247:00 amRNSBoard changes
2nd May 20247:00 amRNSShare subscription, director dealing and TVR
17th Apr 20247:00 amRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSFunding facility, share allotment & PDMR dealing
2nd Apr 20247:00 amRNSTrading update & equity funding facility proposal
28th Dec 20237:00 amRNSInclusion within UN Environment Programme Tool
22nd Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20237:00 amRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSInterim results
28th Nov 20237:00 amRNSAppointment of investor relations adviser and TVR
27th Nov 20237:00 amRNSCorporate development adviser and TVR
15th Nov 20237:00 amRNSDisposal, Loan Conversion, New Project Win & TVR
30th Oct 20237:00 amRNSNew Product Launch
28th Sep 20237:00 amRNSAppointment of Strategic Adviser and TVR
15th Sep 20233:56 pmRNSResult of AGM
15th Sep 20237:00 amRNSAGM Statement
30th Aug 20237:00 amRNSDirector/PDMR Shareholding
24th Aug 20237:00 amRNSDirector/PDMR Shareholding
21st Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
14th Aug 20237:00 amRNSFinal Results, Posting of Report and Notice of AGM
1st Aug 20234:42 pmRNSChange of Registered Office
31st Jul 20235:30 pmRNSTotal Voting Rights
4th Jul 20237:00 amRNSRevision of Convertible Loan Facility Agreement
19th May 20237:00 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSDirector/PDMR Shareholding
28th Apr 20237:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Apr 20237:00 amRNSDeath of Director
24th Apr 20237:02 amRNSEquity subscription
24th Apr 20237:01 amRNSInsig AI Data & Technology Collaboration with FCA
24th Apr 20237:00 amRNSTrading and operations update
9th Mar 20237:00 amRNSInsig AI showcase Generative AI Product Capability
6th Feb 20237:00 amRNSGenerative AI Product Capability
16th Jan 20237:00 amRNSDirector/PDMR Shareholding
9th Jan 20237:00 amRNSConvertible Loan Facility Drawdown
28th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20227:00 amRNSDirector Dealing
22nd Dec 20227:00 amRNSRevision of Convertible Loan Facility Agreements
21st Dec 20227:00 amRNSDirectors gift shares to Company treasury & TVR
19th Dec 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.